Emin Fadillioglu

Emin Fadillioglu, MD, serves as the Chairman of Eczacıbaşı Evital since September 2022, leading a digital health startup focused on democratizing healthcare management. Fadillioglu has been the CEO of Eczacıbaşı Pharmaceutical and Industrial Investment since April 2021, overseeing three healthcare entities with 1,200 employees. With extensive experience at GSK from 2012 to 2021 as Senior Vice President for Emerging Markets, Fadillioglu achieved significant business transformations and was recognized for establishing a great workplace culture. Prior to GSK, Fadillioglu held various leadership positions at Abbott from 1996 to 2012, including General Manager for Turkey and Division Vice President for Europe, Middle East, and Africa, driving substantial growth and cultural transformation. Fadillioglu's academic qualifications include an MD from İstanbul Üniversitesi-Cerrahpaşa and an MBA from Marmara University.